ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California. Show more
640 FIFTH AVENUE, NEW YORK, NY, UNITED STATES, 10019, New York, NY, 10019, USA
Market Cap
738.6M
52 Wk Range
$10.07 - $19.69
Previous Close
$13.26
Open
$13.83
Volume
2,027,004
Day Range
$13.67 - $14.15
Enterprise Value
726.7M
Cash
1.253M
Avg Qtr Burn
-326.1K
Insider Ownership
6.33%
Institutional Own.
67.91%
Qtr Updated
06/30/26
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|